introduction fungi communicate extracellular environment producing releasing small diffusible chemical signaling molecule known fungal quorum-sensing molecule qsm fungal qsms shown variety biological activity cell-to-cell communication morphogenesis biofilm formation virulence ultimately control growth another fungi date main group qsms including farnesol foh tyrosol tyr phenylethanol tryptophol toh tryptophol toh molecular weight 161.20 qsm isolated yeast candida albicans saccharomyces cerevisiae previous study demonstrated toh inhibit growth candida albicans scedosporium apiospermum thus toh high potential developed innovative product containing active antifungal agent treatment fungal infection develop product containing toh vehicle used incorporate toh dermal delivery greatly concern repeated topical application toh may adversely cause skin irritation contact dermatitis emulsion-based formulation currently chosen formulation topical delivery active agent show good interaction skin aim study investigate antifungal effect toh-containing emulgel vitro skin irritation vivo well healthy human volunteer moreover cosmeceutical benefit toh-containing emulgel also investigated result formulation evaluation toh-containing emulgel aim develop toh-containing emulgel emulgel base recipe emulgel prototype product containing toh successfully developed physical chemical property toh-containing emulgel evaluated previously moreover emulgel containing voriconazole voz also produced parameter emulgel base toh- voz-containing emulgel presented table manufactured toh- voz- containing emulgel appeared white translucent homogenous non-greasy however high concentration active compound toh voz caused increase viscosity reduced spread ability product table phase separation found manufactured emulgel formulation color change physical instability involving phase separation inconsistency increase nevertheless manufactured emulgel formulation found acceptable range 4.5-5.5 table physical property different optimized emulgel formulation full size table antifungal susceptibility toh-containing emulgel in-vitro antifungal activity manufactured toh-containing emulgel formulation evaluated strain fungal pathogen using agar spot assay firstly colony diameter azole-resistant/or azole-sensitive strain including scedosporium apiospermum cbs boydii cbs lomentospora prolificans cm324 aspergillus fumigatus cl-262 fumigatus af293 candida albicans atcc albicans atcc determined day incubation emulgel base toh- voz-containing emulgel table moreover result showed toh-containing emulgel remarkedly lessened growth rate azole-resistant strain toh- voz-containing emulgel colony diameter common fungal skin pathogen investigated group hyaline mold toh-containing emulgel remarkedly lessened growth rate trichophyton mentagrophytes atcc mya-4439 rubrum atcc mya-4438 verrucosum atcc tonsurans microsporum canis gypseum epidermophyton floccosum atcc toh- voz-containing emulgel group dematiaceous mold toh-containing emulgel remarkedly lessened growth rate recifei atcc fonsecaea pedrosoi dermatitidis atcc bipolaris maydis toh- voz-containing emulgel moreover toh-containing emulgel remarkedly lessened growth rate dimorphic fungi sporothrix schenckii atcc talaromyces marneffei toh- voz-containing emulgel pathogenic yeast toh-containing emulgel remarkedly lessened growth rate malassezia furfur atcc asahii atcc tropicalis dubliniensis atcc mya-646 cryptococcus neoformans atcc gattii atcc lodderomyces elongisporus atcc mucor spp rhizopus spp. beauveria bassiana atcc toh- voz-containing emulgel thus effective concentration toh-containing emulgel chosen due board antifungal activity table colony diameter tryptophol toh -containing emulgels treated fungal pathogen incubation day full size table vitro human foreskin fibroblast cell viability cytotoxicity determine potential use topical toh-containing emulgel human foreskin fibroblast hff-1 cell viability cytotoxicity investigated incubating toh voz using mtt 4,5- dimethylthiazol-2-yl -2,5-diphenyl tetrazolium bromide mitogreen lactate dehydrogenase ldh dual acridine orange/ethidium bromide ao/eb staining assay result showed hff-1 cell viability show significant change treating toh determined mtt mitogreen assay fig however hff-1 cell viability 7.50 8.50 respectively significantly decreased voz compared control moreover incubation toh induce hff-1 cell cytotoxicity determined ldh dual ao/eb staining assay whereas voz significantly increased hff-1 cell cytotoxicity 2.50 4.50 respectively compared control fig thus result suggested toh exhibit antifungal activates common skin pathogenic fungi without compromising health human skin vitro figure cell viability cytotoxicity toh-treated human foreskin fibroblast hff- cell determined mtt mitogreen ldh dual ao/eb staining assay percentage cell viability cytotoxicity shown mean 0.05 0.0001 indicate significant difference compared control group concentration toh tryptophol voz voriconazole full size image evaluation toh-containing emulgel mouse skin irritation single irritation test mouse skin used examined acute irritant contact dermatitis aicd toh-containing emulgel post-topical application croton oil sodium lauryl sulfate able induce mild moderate edema loss skin crease whereas emulgel cream base commercial shielding cream voz-containing emulgel toh-containing emulgel induce skin change determined visual assessment notable histological feature acute irritant contact dermatitis spongiosis accumulation fluid epidermis inflammatory cell infiltration epidermis dermis subcutaneous tissue group treated croton oil fig lessened group treated fig histological characteristic aicd found group treated emulgel cream base fig commercial shielding cream fig voz-containing emulgel fig toh-containing emulgel fig figure representative photograph mouse skin post-topical application toh-containing emulgel emulgel cream base commercial shielding cream voz emulgel croton oil toh emulgel arrow indicated spongiosis epidermis dash box magnified specific black white arrowhead indicated inflammatory cell infiltration epidermis dermis respectively scale bar full size image cumulative irritation test mouse skin used examined chronic irritant contact dermatitis cicd toh-containing emulgel severe epidermal hyperplasia spongiosis inflammatory cell infiltration dilatation dermal vessel found group treated croton oil day fig day application fig lessened group treated day fig day application fig histological characteristic cicd found group treated emulgel cream base fig commercial shielding cream fig voz-containing emulgel fig toh-containing emulgel fig day day application respectively therefore present study suggested toh-containing emulgel induce neither acute chronic irritation vivo figure representative photograph mouse skin day topical application toh-containing emulgel emulgel cream base commercial shielding cream voz emulgel croton oil toh emulgel arrow indicated spongiosis epidermis dash box magnified specific black arrowhead indicated inflammatory cell infiltration epidermis scale bar full size image figure representative photograph mouse skin day topical application toh-containing emulgel emulgel cream base commercial shielding cream voz emulgel croton oil toh emulgel arrow indicated spongiosis epidermis dash box magnified specific black arrowhead indicated inflammatory cell infiltration epidermis scale bar full size image evaluation toh-containing emulgel human skin irritation skin irritation test determined thirty healthy volunteer topical treatment toh-containing emulgel post-topical application visual characteristic skin irritation dermatitis observed group treated commercial shielding cream fig toh-containing emulgel fig voz-containing emulgel fig emulgel cream base fig moreover skin irritation observed post-topical application treatment fig therefore present study suggested toh-containing emulgel treatment cause skin irritation human volunteer figure representative photograph skin reaction commercial shielding cream toh-containing emulgel voz-containing emulgel emulgel cream base post- post-topical application full size image evaluation toh-containing emulgel human skin physiological property hydration value measured skin volunteer treated toh-containing emulgel significantly higher emulgel base distilled water treated area fig skin hydration significantly increased treated toh-containing emulgel fig moreover treatment toh-containing emulgel significantly reduced transepidermal water loss tewl product fig therefore present study suggested toh-containing emulgel treatment enhances cosmeceutical benefit human skin figure noninvasive assessment skin hydration percentage hydration change tewl reading day post-application toh-containing emulgel data shown mean 0.01 0.0001 indicate significant difference compared control group concentration toh tryptophol full size image discussion superficial mycosis caused pathogenic fungi affect superficial layer skin several specie human pathogenic fungi infect deeper superficial layer skin causing cutaneous mycosis skin mycoses common worldwide case causing cosmetically poor appearance severe inflammation antifungal drug voriconazole voz triazole compound drug-of-choice antifungal agent fungal infection however fungal infection resistant triazoles voz become concern increase case past decade thus present study conducted developed evaluate effectiveness alternative topical treatment treat various pathogenic fungi tryptophol toh -containing emulgel general toh naturally found quorum sensing molecule qsm seed plant bacteria fungi toh affect fungi morphogenesis provides potential use antifungal agent various fungal pathogen specie previously demonstrated vitro treatment toh suppresses pathogenicity albicans addition treatment toh found induce albicans apoptosis via transcriptional upregulation caspase recruitment domain-containing protein card noxa downregulation bcl-2 also previously demonstrated treatment toh reduces germ tube length biofilm formation apiospermum vitro moreover toh-containing emulgel developed reduced apiospermum -induced eumycetoma formation vivo also antifungal activity toh vitro vivo extensively studied whether antifungal activity safety toh-containing emulgel clinical use remains elucidated present study demonstrated toh successfully incorporated emulgel base containing sepigel moreover toh-containing emulgel present study exhibited excellent cosmeceutical level including homogeneity consistency stability range 5.5 compromised skin interestingly demonstrated toh-containing emulgel exhibited excellent antifungal activity pathogenic fungi including azole-resistant strain hyaline dematiaceous mold dimorphic fungi yeast voz-containing emulgel vitro thus study suggested manufactured toh-containing emulgel optimal topical use vivo antifungal activity wide range human cutaneous pathogenic fungi report demonstrated toh caused cytotoxic human foreskin fibroblast hff-1 cell voz vitro suggesting toh safe use topical treatment vivo determined safety use toh-containing emulgel human volunteer determining acute irritant contact dermatitis aicd chronic irritant contact dermatitis cicd caused toh-containing emulgel prior commercialize product present study result suggested either single repeated exposure toh-containing emulgel doe cause skin irritation histological change suitable long term use skin irritation observed human volunteer toh-containing emulgel treatment moreover skin hydration water loss gained toh-containing emulgel treatment therefore present study showed toh-containing emulgel suitable used alternative antifungal product topical treatment hence possible infer toh-containing emulgel safe topical application human skin without skin adverse effect nevertheless antifungal activity toh-containing emulgel need evaluated patient cutaneous fungal infection plan investigate near future conclusion study confirmed positive effect toh-containing emulgel exhibit antifungal activity cosmeceutical benefit without causing skin irritation human potential use toh-containing emulgel patient skin mycoses may investigated future study showed innovative approach utilize toh-containing emulgel topical application treating fungal infection accordance growing use emulgels cosmeceutical pharmacological product method material tryptophol toh c10h11no voriconazole voz absolute ethanol etoh tween glycerin propylene glycol allantoin phenoxyethanol acridine orange/ethidium bromide ao/eb sodium lauryl sulfate croton oil purchased sigma-aldrich st. louis usa sepigel purchased seppic inc. fairfield usa triethanolamine purchased dow chemical thailand deionized water used experiment produced in-house milli-q ultrapure water system emd millipore bedford usa sabouraud dextrose agar sda potato dextrose agar pda purchased oxoid ltd. hampshire roswell park memorial institute medium rpmi-1640 fetal bovine serum fbs penicillin-streptomycin pen-strep phosphate-buffered saline trypsin-edta purchased gibco™ grand island usa mtt 4,5- dimethylthiazol-2-yl -2,5-diphenyl tetrazolium bromide purchased bio basic inc. canada cytopainter mitogreen ab176830 purchased abcam cytotox non-radioactive cytotoxicity assay measuring release lactate dehydrogenase ldh purchased promega madison usa reagent used study high purity hplc grade preparation toh-containing emulgel formulation emulgel formulation prepared either tryptophol voriconazole according kitisin optimization emulgel formulation performed evaluating effect different concentration excipients based visual change appearance homogeneity consistency viscosity stability change physical characteristic prior manufacturing final formulation composition optimized emulgel formula provided table table composition different optimized emulgel formulation w/w full size table manufacturing process emulgel emulgel base manufactured constant mechanical stirring gel-based sepigel toh voz accurately prepared added emulgel base vigorously mixed smooth emulgel formed visual evaluation visual appearance manufactured emulgel formulation examined physical appearance including color homogeneity consistency phase separation measurement viscosity viscosity manufactured emulgel formulation evaluated room temperature using brookfield viscometer brookfield model programmable dv2 usa volume sample 0.5 formulated emulgel sample left equilibrium min measurement spindle determined rpm min viscosity reading sample recorded moreover manufactured emulgel formulation measured digital meter thermo fisher scientific waltham usa prior measurement meter calibrated using standard buffer emulgel formulation recorded meter probe washed measurement water v/v etoh data analyzed tripiclate measurement spreadability spreadability manufactured emulgel formulation investigated determine competence emulgel formulation able spread evenly smeared affected skin measure spreadability emulgel sample formulated emulgel placed onto ground fixed glass plate covered another glass plate placed wooden block definite load placed top slide min provid basis slip drag characteristic emulgel time second required separate two slide recorded analyzed triplicate spreadability calculated using following equation l/t stand spreadability stand weight tied upper slide length glass slide time requires separate slide completely measurement stability physical stability study investigated formulation using using centrifugation temperature cycle test centrifugation test approximately sample centrifuged rpm min addition prepared emulgel sample subject temperature cycle test storing h/a cycle cycle cooling-heating freeze-thaw emulgel sample evaluated stability change measurement performed triplicate physical stability emulgels formulation evaluated end test fungal strain growth condition scedosporium apiospermum cbs boydii cbs lomentospora prolificans cm324 used study kindly provided dr. ana alastruey-izquierdo servicio micologίa instituto salud carlos iii madrid spain aspergillus fumigatus cl-262 azole resistant clinical strain carrying m220i mutation cyp51a gene kindly provided asst prof. dr. marut tangwattanachuleeporn faculty allied health science burapha university chonburi thailand bipolaris maydis kindly provided dr. songbai zhang college agriculture yangtze university hubei china microsporum canis gypseum trichophyton tonsurans talaromyces marneffei mucor spp candida tropicalis unpublished data fonsecaea pedrosoi unpublished data rhizopus spp unpublished data used study clinical environmental isolates previously collected identified laboratory fumigatus af293 atcc mya-4609 cbs azole sensitive strain candida albicans atcc azole sensitive strain albicans atcc azole resistant strain dubliniensis atcc mya-646 cbs mentagrophytes atcc mya-4439 rubrum atcc mya-4438 verrucosum atcc epidermophyton floccosum atcc acremonium recifei atcc exophiala dermatitidis atcc sporothrix schenckii atcc malassezia furfur atcc asahii atcc cryptococcus neoformans atcc gattii atcc lodderomyces elongisporus atcc beauveria bassiana atcc provided american type culture collection atcc manassas usa fungal strain cultured sda yeast pda mold in-vitro antifungal activity study in-vitro antifungal activity study manufactured emulgel formulation evaluated using agar spot assay according horváth yeast according muangkaew filamentous fungi modification briftly ten fungal conidium concentration conidia/ml mixed manufactured emulgel formulation toh 1000μm voz spotted surface sda plate plate incubated day colony diameter measured millimeter using vernier caliper uninoculated sda plate used negative control experiment performed triplicate cell culture viability cytotoxicity human foreskin fibroblast hff-1 cell line atcc scrc-1041™ used investigate cell viability cytotoxicity toh treatment hff-1 cell cultured rpmi-1640 supplemented fbs u/ml pen-strep incubated humidified condition measurement cell viability cytoxicity toh treatment carried using mtt cytopainter mitogreen ldh dual ao/eb staining assay previously described hff-1 seeded concentration cells/ml well plate treated toh 1000μm voz absolute etoh rpmi v/v diluent control untreated hff-1 cell used negative control viable incubation 0.5 μg/μl mtt solution cytotox reagent added measured spectrophotometrically respectively sunrise tecan grödig austria label cell viability toxicity treated hff-1 cell stained mitogreen indicator μg/μl ao/eb solution respectively cellular morphology apoptotic cell number examined zeiss axio imager fluorescence microscope zeiss germany experiment performed triplicate vivo evaluation emulgel formulation mouse skin irritation female balb/c mouse purchased nomura siam international ltd. thailand used evaluate skin irritation manufactured emulgel formulation group included animal aged 6-8-week-old body weight 20–25 skin irritation mouse model produced validated described previously modification briefly mouse topically treated various concentration manufactured emulgel formulation including emulgel base toh voz containing emulgels cause necrosis epidermis five percentage croton oil used irritant commercial shielding cream applied control single irritation irritant put finn chamber scanpor tape epitest ltd. finland applied dorsal skin animal polyurethane film 3m™ tegaderm™ usa used fix finn chamber removed post-application cumulative irritation procedure repeated day week removing finn chamber mouse sacrificed skin sample collected specimen fixed buffered formalin processed haematoxylin eosin stain skin section examined light microscope bh-2 olympus japan animal experiment conducted accordance animal scientific purpose act b.e a.d. thailand experiment mouse approved institutional animal care use committee iacuc university phayao thailand approval number up-ae64-01-04-017 vivo evaluation emulgel formulation human skin irritation evaluate sensitization potential manufactured emulgel formulation toward human skin skin irritation test performed healthy volunteer single irritation test manufactured emulgel formulation emulgel base toh voz containing emulgels put finn chamber back arm skin volunteer fixed polyurethane film commercial shielding cream applied control finn chamber removed post-application treated area volunteer skin observed immediately removing finn chamber vivo study healthy volunteer complied declaration helsinki approved ethic committee faculty tropical medicine mahidol university thailand approval number mutm 2022-036-01 written informed consent obtained participant vivo evaluation emulgel formulation human skin hydration trans-epidermal water loss tewl skin color evaluate effect manufactured emulgel formulation human skin physiological function including skin hydration trans-epidermal water loss tewl treated skin healthy volunteer manufactured emulgel formulation investigated using dermalab hydration probe tewl probe cortex technology hadsund denmark manufactured emulgel treatment measurement skin hydration tewl performed square middle forearm next interval measurement three measurement taken square statistical analysis data statistically analyzed using graphpad prism version 6.05 graphpad software san diego usa experiment performed triplicate data expressed mean -value 0.05 considered statistically significant using independent -test analysis variance anova followed tukey multiple comparison test institutional review board statement animal experiment conducted accordance animal scientific purpose act b.e a.d. thailand experiment mouse approved institutional animal care use committee iacuc university phayao thailand approval number up-ae64-01-04-017 human study approved ethic committee faculty tropical medicine mahidol university thailand approval number mutm 2022-036-01 informed consent informed consent obtained human subject involved study